PDCD1 and infantile convulsions and choreoathetosis: Here, we discuss a single case by highlighting the usage of the anti-PD-1 drug nivolumab in combination with the receptor tyrosine kinase inhibitor lenvatinib in a 40-year-old female with recurrent and metastatic iCCA after resection.